President Donald Trump announced Monday that TrumpRx.gov will add more than 600 affordable generic drugs to its online platform, a nearly sevenfold expansion of the prescription drug website that the administration says will offer the lowest prices on medications used by tens of millions of Americans.
Trump made the announcement from the South Court Auditorium of the Eisenhower Executive Office Building on the White House campus, flanked by Health and Human Services Secretary Robert F. Kennedy Jr. and Cost Plus Drugs cofounder Mark Cuban.
The expansion represents the most significant scaling of TrumpRx since its launch, and it lands a direct hit on one of the most persistent complaints from American households: the price of prescription medication. The administration is partnering with industry players, including Cuban’s direct-to-consumer online pharmacy Cost Plus Drugs, to bring the generics online.
Trump framed the move as a straightforward win for consumers who either don’t know generics exist or don’t realize how cheaply they can get them. As Breitbart News reported, the president told reporters:
“Today I’m thrilled to announce that we’re increasing the number of drugs available on TrumpRx by nearly seven times, adding over 600 affordable generics to the website, working with industry partners.”
He pressed the point on price, arguing that generic drugs deliver the same dosage, the same effectiveness, and the same active ingredients as brand-name equivalents, often at a fraction of the cost.
“Cost-effective generic drugs are often available at just a tiny fraction of the price of their brand-name equivalents, and in theory, they’re the same thing. Sometimes they’re better with the same dosage, the same effectiveness, and the same active ingredients. Yet many consumers do not think to ask for them. They don’t know about them.”
Trump also made a bold claim about where TrumpRx prices will land relative to insurance copays, a benchmark most consumers treat as the floor.
“With these additions, TrumpRx will feature the best and lowest prices on prescriptions used by tens of millions of Americans already, and in some cases, the discounted generics available through TrumpRx may be offered at an even lower cash price than the out-of-pocket insurance costs, which has always been the lowest. We’re going to be lower.”
If that holds, it would mark a genuine disruption. For years, Americans have assumed their insurance plan negotiated the best deal. A government-backed platform undercutting those copays on hundreds of generics would change the math for millions of households.
HHS Secretary Kennedy used the occasion to draw a sharp contrast between the Trump administration and its predecessors, from both parties. Kennedy said Trump asked him to make America the country with the most affordable medication in the world, then declared the president had delivered.
“I want to say one last thing: President Bush promised to do this, President Clinton promised to do it, President Biden promised to do it, President Obama promised to do it, President Trump actually got it done, and it’s an extraordinary accomplishment, it’s an extraordinary legacy for him, and as a gift to the American people.”
The remark is pointed. Four administrations spanning both parties talked about lowering drug prices. Some passed legislation. Some issued executive orders. None built a consumer-facing platform that lets Americans comparison-shop generics at prices the government says will beat insurance copays. Whether TrumpRx ultimately delivers on every promise remains to be seen, but the platform now exists and is scaling.
Joe Gebbia, the U.S. Chief Design Officer of the National Design Studio, demonstrated the expanded website at Monday’s event. Beyond the 600 new generics, Gebbia highlighted a new feature: an interactive map that lets Americans compare prescription drug prices at local pharmacies.
That feature matters. Drug pricing in America is notoriously opaque. The same medication can cost wildly different amounts at two pharmacies a mile apart. A tool that surfaces those differences, hosted on a.gov domain, gives consumers leverage they haven’t had before.
Perhaps the most striking presence at the announcement was Cuban himself. The Cost Plus Drugs cofounder backed former Vice President Kamala Harris in the 2024 election. Yet there he stood on the White House campus, partnering with the Trump administration on one of its signature domestic policy efforts.
Cuban addressed the room directly, framing the partnership in terms that sidestepped partisan loyalty entirely:
“Mr. President, I think, other than you, I’ve been the biggest proponent of [TrumpRx.gov], and the reason for that is Republicans want cheaper drugs, independents want cheaper drugs, Democrats want cheaper drugs, and together I think we’re going to do something special.”
After the event, Breitbart News caught up with Cuban during a press gaggle outside the West Wing. He urged Americans to check both Costplusdrugs.com and TrumpRx when buying medications, and offered a broader take on what the collaboration means.
“What should happen is, if you’re concerned about health care and you’re buying medications, you should go to Costplusdrugs.com and see if we have it, go to TrumpRx, and see if we have it because you know the way I always look at politics, and any politician, the only thing I care about is can they reduce the stress of the American people.”
He added: “All the politics increases stress. This: TrumpRx and Cost Plus Drugs working together is one step towards reducing the stress.”
Cuban’s presence is telling. A man who spent 2024 campaigning for the other side now stands shoulder-to-shoulder with the administration because the policy works. That kind of crossover doesn’t happen when the results are theoretical. It happens when the numbers on the screen are hard to argue with.
Monday’s announcement was heavy on ambition and light on certain specifics. The administration did not name the 600 generics being added or disclose the exact prices consumers will see. Which industry partners beyond Cost Plus Drugs are involved was not detailed. And the timeline for when the full expanded list goes live on TrumpRx.gov was not made explicit.
Likewise, the interactive pharmacy-comparison map is a promising concept, but the scope of participating local pharmacies remains unclear. Those details will matter when Americans actually log on and start searching.
None of that diminishes the scale of the move. Expanding a government prescription platform sevenfold is a concrete step, not a press release. But the proof will come when consumers test the prices against what they’re paying now, at the pharmacy counter, not in the South Court Auditorium.
Kennedy’s list of presidents who promised and failed to deliver on drug costs is not rhetorical decoration. It’s a factual record. Prescription drug pricing has been a bipartisan talking point for decades. Candidates of every stripe have pledged to bring costs down. Most of those pledges produced incremental changes at best, or vanished entirely once the lobbying started.
TrumpRx takes a different approach. Rather than regulate prices through legislation that can be watered down in committee, the platform creates a direct marketplace. It puts the government in the role of price aggregator and lets consumers see, in real time, what generics cost and where to get them cheapest. The addition of 600 drugs moves it from pilot project to something closer to a functioning national tool.
The partnership with Cost Plus Drugs adds credibility. Cuban’s company built its reputation on transparent pricing, a flat markup, a small pharmacy fee, no hidden middlemen. Pairing that model with a.gov platform backed by the full weight of the executive branch creates competitive pressure that the traditional pharmacy-benefit-manager system has never faced from Washington.
Whether the pharmaceutical industry, insurance carriers, and PBMs respond with lower prices of their own or fight the platform through regulatory and legal channels is a question for the coming months. But for now, the administration has put 600 more generics on the board and dared the market to beat its prices.
Four presidents talked about it. One built the website. The scoreboard doesn’t care about speeches, it cares about what the prescription costs when you pick it up.
By signing up, you agree to receive newsletters and promotional content from American Frontline News and selected publications in the American Digest Media Network, operated with Patriot Mom Digest LLC, and you accept our Terms of Use and Privacy Policy. You may unsubscribe at any time.
By signing up, you agree to receive newsletters and promotional content from American Frontline News and selected publications in the American Digest Media Network, operated with Patriot Mom Digest LLC, and you accept our Terms of Use and Privacy Policy. You may unsubscribe at any time.